Subscribe to RSS
Please copy the URL and add it into your RSS Feed Reader.
https://www.thieme-connect.de/rss/thieme/en/10.1055-s-00000167.xml
Download PDF
Int J Angiol
DOI: 10.1055/a-2624-5607
DOI: 10.1055/a-2624-5607
Review Article
The History of Coronary Artery Disease
Abstract
Coronary artery disease (CAD) is the leading cause of mortality worldwide and although often considered a modern disease its origins trace back to ancient civilizations. This historical review explores the evolution of understanding, diagnosis, and treatment of CAD. It will discuss early evidence of atherosclerosis in mummies through pioneers in the field of medical and surgical understanding to innovative surgical and interventional advances in the modern era. The progression of medical therapies, including the discovery and utilization of digitalis, nitrates, aspirin, beta blockers, and statins, is discussed alongside the evolution of catheter-based and surgical interventions such as percutaneous coronary intervention (PCI) and coronary artery bypass grafting (CABG). Future therapies will be briefly discussed. Despite remarkable progress, CAD remains a major public health challenge, emphasizing the importance of continued innovation in prevention, diagnosis, and treatment. Understanding the historical trajectory of CAD provides critical insights for shaping the future of cardiovascular medicine.
Keywords
coronary artery disease - angina pectoris - coronary angiography - percutaneous coronary intervention - coronary artery bypass graftingPublication History
Article published online:
27 June 2025
© 2025. International College of Angiology. This article is published by Thieme.
Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA
-
References
- 1 World Health Organization. . The top 10 causes of death. Geneva: World Health Organization; August 7, 2024 . Accessed April 27, 2025 at: https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death
- 2 Murphy SL, Kochanek KD, Xu J, Arias E. Mortality in the United States, 2023. 2024 Dec. In: NCHS Data Briefs [Internet]. Hyattsville, MD: National Center for Health Statistics (US); July 2024 . No. 521. Accessed at: https://www.ncbi.nlm.nih.gov/books/NBK611296/
- 3 Mahmood SS, Levy D, Vasan RS, Wang TJ. The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective. Lancet 2014; 383 (9921) 999-1008
- 4 Golub IS, Termeie OG, Kristo S. et al. Major global coronary artery calcium guidelines. JACC Cardiovasc Imaging 2023; 16 (01) 98-117
- 5 Nykonenko A, Feuchtner G, Nykonenko O. et al. Feasibility of coronary CT angiography for guidance of CABG. J Cardiovasc Comput Tomogr 2021; 15 (03) 281-284
- 6 Serruys PW, Kageyama S, Pompilio G. et al. Coronary bypass surgery guided by computed tomography in a low-risk population. Eur Heart J 2024; 45 (20) 1804-1815
- 7 Stevenson A, Kirresh A, Ahmad M, Candilio L. Robotic-assisted PCI: the future of coronary intervention?. Cardiovasc Revasc Med 2022; 35: 161-168
- 8 Dalen JE, Alpert JS, Goldberg RJ, Weinstein RS. The epidemic of the 20(th) century: coronary heart disease. Am J Med 2014; 127 (09) 807-812
- 9 Duggan JP, Peters AS, Trachiotis GD, Antevil JL. Epidemiology of coronary artery disease. Surg Clin North Am 2022; 102 (03) 499-516
- 10 Hajar R. Coronary heart disease: from mummies to 21st century. Heart Views 2017; 18 (02) 68-74
- 11 von Staden H. The discovery of the body: human dissection and its cultural contexts in ancient Greece. Yale J Biol Med 1992; 65 (03) 223-241
- 12 Medicine in Ancient Egypt Part 2 of 3 | Arab World Books. Accessed June 13, 2025 at: https://en.wikipedia.org/wiki/Portrait_of_Dr._Gachet
- 13 Hajar Albinali HA, Majnoon Lila. DrHajar Info website. Published 2019. Accessed June 16, 2025 at: https://www.drhajar.info/majnoon-lila?lang=en
- 14 Wells FC. Leonardo's Heart. In: The Heart of Leonardo. London: Springer; 2013
- 15 Mesquita ET, Souza Júnior CV, Ferreira TR. Andreas Vesalius 500 years—a Renaissance that revolutionized cardiovascular knowledge. Braz J Cardiovasc Surg 2015; 30 (02) 260-265
- 16 Ribatti D. William Harvey and the discovery of the circulation of the blood. J Angiogenes Res 2009; 1: 3
- 17 Lichtlen PR. History of coronary heart disease. Z Kardiol 2002; 91 (Suppl. 04) 56-59
- 18 Donoso F A, Arriagada S D. René Théophile Hyacinthe Laënnec (1781-1826). Two hundred years of the stethoscope. A brief overview. Arch Argent Pediatr 2020; 118 (05) e444-e448
- 19 Boden WE, Kaski JC, Berry C. Reprising Heberden's description of angina pectoris after 250 years. Eur Heart J 2023; 44 (19) 1684-1686
- 20 Golden RL. Sir William Osler's angina pectoris and other disorders. Am J Cardiol 1987; 60 (01) 175-178
- 21 Olszewski TM. James Herrick (1861-1954): consultant physician and cardiologist. J Med Biogr 2018; 26 (02) 132-136
- 22 Bourassa MG. The history of cardiac catheterization. Can J Cardiol 2005; 21 (12) 1011-1014
- 23 Kidambi S, Massad MG. On van Gogh and the foxglove plant. Cardiology 2014; 127 (03) 164-166
- 24 Fye WB. Vasodilator therapy for angina pectoris: the intersection of homeopathy and scientific medicine. J Hist Med Allied Sci 1990; 45 (03) 317-340
- 25 Ittaman SV, VanWormer JJ, Rezkalla SH. The role of aspirin in the prevention of cardiovascular disease. Clin Med Res 2014; 12 (3-4): 147-154
- 26 Oliver E, Mayor Jr F, D'Ocon P. Beta-blockers: historical perspective and mechanisms of action. Rev Esp Cardiol (Engl Ed) 2019; 72 (10) 853-862
- 27 Joseph P, Swedberg K, Leong DP, Yusuf S. The evolution of β-blockers in coronary artery disease and heart failure (Part 1/5). J Am Coll Cardiol 2019; 74 (05) 672-682
- 28 Endo A. A historical perspective on the discovery of statins. Proc Jpn Acad, Ser B, Phys Biol Sci 2010; 86 (05) 484-493
- 29 Virani SS, Newby LK, Arnold SV. et al; Peer Review Committee Members. 2023 AHA/ACC/ACCP/ASPC/NLA/PCNA guideline for the management of patients with chronic coronary disease: a report of the American Heart Association/American College of Cardiology Joint Committee on Clinical Practice Guidelines. Circulation 2023; 148 (09) e9-e119 . Erratum in: Circulation. 2023 Sep 26;148(13):e148. Erratum in: Circulation. 2023 Dec 5;148(23):e186
- 30 Stead LF, Buitrago D, Preciado N, Sanchez G, Hartmann-Boyce J, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev 2013; 2013 (05) CD000165
- 31 Baigent C, Blackwell L, Emberson J. et al; Cholesterol Treatment Trialists' (CTT) Collaboration. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 2010; 376 (9753) 1670-1681
- 32 Neter JE, Stam BE, Kok FJ, Grobbee DE, Geleijnse JM. Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials. Hypertension 2003; 42 (05) 878-884
- 33 Zinman B, Wanner C, Lachin JM. et al; EMPA-REG OUTCOME Investigators. Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes. N Engl J Med 2015; 373 (22) 2117-2128
- 34 Antithrombotic Trialists' Collaboration. Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 2002; 324 (7329) 71-86 . Erratum in: BMJ 2002 Jan 19;324(7330):141
- 35 Dargie HJ. Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial. Lancet 2001; 357 (9266) 1385-1390
- 36 Flather MD, Yusuf S, Køber L. et al; ACE-Inhibitor Myocardial Infarction Collaborative Group. Long-term ACE-inhibitor therapy in patients with heart failure or left-ventricular dysfunction: a systematic overview of data from individual patients. Lancet 2000; 355 (9215) 1575-1581
- 37 Heidenreich PA, McDonald KM, Hastie T. et al. Meta-analysis of trials comparing beta-blockers, calcium antagonists, and nitrates for stable angina. JAMA 1999; 281 (20) 1927-1936
- 38 Reimer KA, Jennings RB. The “wavefront phenomenon” of myocardial ischemic cell death. II. Transmural progression of necrosis within the framework of ischemic bed size (myocardium at risk) and collateral flow. Lab Invest 1979; 40 (06) 633-644
- 39 DeWood MA, Spores J, Notske R. et al. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med 1980; 303 (16) 897-902
- 40 Chazov EI, Matveeva LS, Mazaev AV, Sargin KE, Sadovskaia GV, Ruda MI. [Intracoronary administration of fibrinolysin in acute myocardial infarct]. Ter Arkh 1976; 48 (04) 8-19
- 41 Rentrop KP, Blanke H, Karsch KR. et al. Acute myocardial infarction: intracoronary application of nitroglycerin and streptokinase. Clin Cardiol 1979; 2 (05) 354-363
- 42 Effectiveness of intravenous thrombolytic treatment in acute myocardial infarction. Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico (GISSI). Lancet 1986; 1 (8478) 397-402
- 43 GUSTO investigators. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med 1993; 329 (10) 673-682
- 44 Van De Werf F, Adgey J, Ardissino D. et al; Assessment of the Safety and Efficacy of a New Thrombolytic (ASSENT-2) Investigators. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial. Lancet 1999; 354 (9180) 716-722
- 45 Boersma E, Maas AC, Deckers JW, Simoons ML. Early thrombolytic treatment in acute myocardial infarction: reappraisal of the golden hour. Lancet 1996; 348 (9030) 771-775
- 46 Topol EJ. Acute myocardial infarction: thrombolysis. Heart 2000; 83 (01) 122-126
- 47 Keeley EC, Boura JA, Grines CL. Primary angioplasty versus intravenous thrombolytic therapy for acute myocardial infarction: a quantitative review of 23 randomised trials. Lancet 2003; 361 (9351) 13-20
- 48 Boersma E. Primary Coronary Angioplasty vs. Thrombolysis Group. Does time matter? A pooled analysis of randomized clinical trials comparing primary percutaneous coronary intervention and in-hospital fibrinolysis in acute myocardial infarction patients. Eur Heart J 2006; 27 (07) 779-788
- 49 Keeley EC, Boura JA, Grines CL. Comparison of primary and facilitated percutaneous coronary interventions for ST-elevation myocardial infarction: quantitative review of randomised trials. Lancet 2006; 367 (9510) 579-588 . Erratum in: Lancet. 2006 May 20;367(9523):1656
- 50 Armstrong PW, Gershlick AH, Goldstein P. et al; STREAM Investigative Team. Fibrinolysis or primary PCI in ST-segment elevation myocardial infarction. N Engl J Med 2013; 368 (15) 1379-1387
- 51 Danchin N, Puymirat E, Steg PG. et al; FAST-MI 2005 Investigators. Five-year survival in patients with ST-segment-elevation myocardial infarction according to modalities of reperfusion therapy: the French Registry on Acute ST-Elevation and Non-ST-Elevation Myocardial Infarction (FAST-MI) 2005 Cohort. Circulation 2014; 129 (16) 1629-1636
- 52 Van de Werf F. The history of coronary reperfusion. Eur Heart J 2014; 35 (37) 2510-2515
- 53 Barton M, Grüntzig J, Husmann M, Rösch J. Balloon angioplasty—the legacy of Andreas Grüntzig, M.D. (1939-1985). Front Cardiovasc Med 2014; 1: 15
- 54 Stefanini GG, Byrne RA, Windecker S, Kastrati A. State of the art: coronary artery stents—past, present and future. EuroIntervention 2017; 13 (06) 706-716
- 55 Grech ED. ABC of interventional cardiology: percutaneous coronary intervention. I: history and development. BMJ 2003; 326 (7398) 1080-1082
- 56 Schmidt T, Abbott JD. Coronary stents: history, design, and construction. J Clin Med 2018; 7 (06) 126
- 57 Lawton JS, Tamis-Holland JE, Bangalore S. et al. 2021 ACC/AHA/SCAI guideline for coronary artery revascularization: a report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation 2022; 145 (03) e18-e114 . Erratum in: Circulation. 2022 Mar 15;145(11):e772
- 58 Hochman JS, Sleeper LA, Webb JG. et al. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should We Emergently Revascularize Occluded Coronaries for Cardiogenic Shock. N Engl J Med 1999; 341 (09) 625-634
- 59 Mehta SR, Cannon CP, Fox KA. et al. Routine vs selective invasive strategies in patients with acute coronary syndromes: a collaborative meta-analysis of randomized trials. JAMA 2005; 293 (23) 2908-2917
- 60 Acharya D, Gulack BC, Loyaga-Rendon RY. et al. Clinical characteristics and outcomes of patients with myocardial infarction and cardiogenic shock undergoing coronary artery bypass surgery: data from the Society of Thoracic Surgeons National Database. Ann Thorac Surg 2016; 101 (02) 558-566
- 61 Gaudino M, Hameed I, Khan FM. et al. Treatment strategies in ischaemic left ventricular dysfunction: a network meta-analysis. Eur J Cardiothorac Surg 2020; ezaa319 . Epub ahead of print
- 62 Rocha EAV. Fifty years of coronary artery bypass graft surgery. Braz J Cardiovasc Surg 2017; 32 (04) II-III
- 63 Holman WL, Timpa J, Kirklin JK. Origins and evolution of extracorporeal circulation: JACC historical breakthroughs in perspective. J Am Coll Cardiol 2022; 79 (16) 1606-1622
- 64 Rohman M, Goetz RH, Dee R. Double coronary artery-internal mammary artery anastomoses, tantalum ring technique. Surg Forum 1960; 11: 236-237
- 65 Konstantinov IE. The first coronary artery bypass operation and forgotten pioneers. Ann Thorac Surg 1997; 64 (05) 1522-1523
- 66 Kolessov VI. Mammary artery-coronary artery anastomosis as method of treatment for angina pectoris. J Thorac Cardiovasc Surg 1967; 54 (04) 535-544
- 67 Favaloro RG. Saphenous vein autograft replacement of severe segmental coronary artery occlusion: operative technique. Ann Thorac Surg 1968; 5 (04) 334-339
- 68 Shelton ME, Forman MB, Virmani R, Bajaj A, Stoney WS, Atkinson JB. A comparison of morphologic and angiographic findings in long-term internal mammary artery and saphenous vein bypass grafts. J Am Coll Cardiol 1988; 11 (02) 297-307
- 69 Otsuka F, Yahagi K, Sakakura K, Virmani R. Why is the mammary artery so special and what protects it from atherosclerosis?. Ann Cardiothorac Surg 2013; 2 (04) 519-526
- 70 Loop FD, Lytle BW, Cosgrove DM. et al. Influence of the internal-mammary-artery graft on 10-year survival and other cardiac events. N Engl J Med 1986; 314 (01) 1-6
- 71 Cameron A, Davis KB, Green G, Schaff HV. Coronary bypass surgery with internal-thoracic-artery grafts—effects on survival over a 15-year period. N Engl J Med 1996; 334 (04) 216-219
- 72 Zhang M, Guddeti RR, Matsuzawa Y. et al. Left internal mammary artery versus coronary stents: impact on downstream coronary stenoses and conduit patency. J Am Heart Assoc 2016; 5 (09) e003568
- 73 Sauvage LR, Wu HD, Kowalsky TE. et al. Healing basis and surgical techniques for complete revascularization of the left ventricle using only the internal mammary arteries. Ann Thorac Surg 1986; 42 (04) 449-465
- 74 Raja SG, Dreyfus GD. Internal thoracic artery: to skeletonize or not to skeletonize?. Ann Thorac Surg 2005; 79 (05) 1805-1811
- 75 Laugesen S, Krasniqi L, Benhassen LL. et al. How to harvest the left internal mammary artery—a randomized controlled trial. Interdiscip Cardiovasc Thorac Surg 2024; 38 (05) ivae102
- 76 Buffolo E, de Andrade CS, Branco JN, Teles CA, Aguiar LF, Gomes WJ. Coronary artery bypass grafting without cardiopulmonary bypass. Ann Thorac Surg 1996; 61 (01) 63-66
- 77 Benetti FJ, Naselli G, Wood M, Geffner L. Direct myocardial revascularization without extracorporeal circulation. Experience in 700 patients. Chest 1991; 100 (02) 312-316
- 78 Pfister AJ, Zaki MS, Garcia JM. et al. Coronary artery bypass without cardiopulmonary bypass. Ann Thorac Surg 1992; 54 (06) 1085-1091 , discussion 1091–1092
- 79 Calafiore AM, Vitolla G, Mazzei V. et al. The LAST operation: techniques and results before and after the stabilization era. Ann Thorac Surg 1998; 66 (03) 998-1001
- 80 Hart JC, Puskas JD, Sabik III JF. Off-pump coronary revascularization: current state of the art. Semin Thorac Cardiovasc Surg 2002; 14 (01) 70-81
- 81 Takagi H, Ando T, Mitta S. ALICE (All-Literature Investigation of Cardiovascular Evidence) group. Meta-analysis comparing ≥10-year mortality of off-pump versus on-pump coronary artery bypass grafting. Am J Cardiol 2017; 120 (11) 1933-1938
- 82 Sabik III JF, Mehaffey JH, Badhwar V. et al. Multiarterial vs single-arterial coronary surgery: 10-year follow-up of 1 million patients. Ann Thorac Surg 2024; 117 (04) 780-788
- 83 Jameie M, Valinejad K, Pashang M. et al. Impact of multiarterial revascularization on long-term major adverse cardiovascular events after coronary bypass in 23,798 patients. Ann Thorac Surg 2024; 118 (04) 863-872
- 84 Bianco V, Mulukutla S, Aranda-Michel E. et al. Coronary artery bypass with multiarterial grafting vs percutaneous coronary intervention. Ann Thorac Surg 2023; 115 (02) 404-410
- 85 Gaudino M, Rahouma M, Abouarab A. et al. Meta-analysis comparing outcomes of drug eluting stents versus single and multiarterial coronary artery bypass grafting. Am J Cardiol 2018; 122 (12) 2018-2025
- 86 Leyvi G, Dabas A, Leff JD. Hybrid coronary revascularization—current state of the art. J Cardiothorac Vasc Anesth 2019; 33 (12) 3437-3445
- 87 Subramanian VA, McCabe JC, Geller CM. Minimally invasive direct coronary artery bypass grafting: two-year clinical experience. Ann Thorac Surg 1997; 64 (06) 1648-1653 , discussion 1654–1655
- 88 Saha T, Naqvi SY, Goldberg S. Hybrid revascularization: a review. Cardiology 2018; 140 (01) 35-44
- 89 Nagraj S, Tzoumas A, Kakargias F. et al. Hybrid coronary revascularization (HCR) versus coronary artery bypass grafting (CABG) in multivessel coronary artery disease (MVCAD): a meta-analysis of 14 studies comprising 4226 patients. Catheter Cardiovasc Interv 2022; 100 (07) 1182-1194
- 90 Mirhoseini M, Cayton MM. Transmyocardial laser revascularization: historical background and future directions. J Clin Laser Med Surg 1997; 15 (06) 245-253
- 91 Allen KB, Mahoney A, Aggarwal S. et al. Transmyocardial revascularization (TMR): current status and future directions. Indian J Thorac Cardiovasc Surg 2018; 34 (Suppl. 03) 330-339
- 92 Briones E, Lacalle JR, Marin-Leon I, Rueda JR. Transmyocardial laser revascularization versus medical therapy for refractory angina. Cochrane Database Syst Rev 2015; 2015 (02) CD003712
- 93 Mohr FW, Morice MC, Kappetein AP. et al. Coronary artery bypass graft surgery versus percutaneous coronary intervention in patients with three-vessel disease and left main coronary disease: 5-year follow-up of the randomised, clinical SYNTAX trial. Lancet 2013; 381 (9867) 629-638
- 94 Farkouh ME, Domanski M, Dangas GD. et al; FREEDOM Follow-On Study Investigators. Long-term survival following multivessel revascularization in patients with diabetes: the FREEDOM Follow-On study. J Am Coll Cardiol 2019; 73 (06) 629-638
- 95 Assimes TL, Roberts R. Genetics: implications for prevention and management of coronary artery disease. J Am Coll Cardiol 2016; 68 (25) 2797-2818
- 96 Steg PG, Ducrocq G. Future of the prevention and treatment of coronary artery disease. Circ J 2016; 80 (05) 1067-1072
- 97 Doenst T, Thiele H, Haasenritter J, Wahlers T, Massberg S, Haverich A. The treatment of coronary artery disease. Dtsch Arztebl Int 2022; 119 (42) 716-723
- 98 Malakar AK, Choudhury D, Halder B, Paul P, Uddin A, Chakraborty S. A review on coronary artery disease, its risk factors, and therapeutics. J Cell Physiol 2019; 234 (10) 16812-16823
- 99 Omerovic E, Råmunddal T, Petursson P. et al. Percutaneous vs. surgical revascularization of non-ST-segment elevation myocardial infarction with multivessel disease: the SWEDEHEART registry. Eur Heart J 2025; 46 (06) 518-531